Cargando…

Genetic modifiers of p53: opportunities for breast cancer therapies

Detalles Bibliográficos
Autores principales:	Majhi, Prabin Dhangada, Sharma, Aman, Jerry, D. Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2023
Materias:	Editorial Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038353/ https://www.ncbi.nlm.nih.gov/pubmed/36961913 http://dx.doi.org/10.18632/oncotarget.28387

Ejemplares similares

Effects of Benzophenone-3 and Propylparaben on Estrogen Receptor–Dependent R-Loops and DNA Damage in Breast Epithelial Cells and Mice
por: Majhi, Prabin Dhangada, et al.
Publicado: (2020)

Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
por: Muller, Patricia A.J., et al.
Publicado: (2014)

Opportunities and limitations of genetically modified nonhuman primate models for neuroscience research
por: Feng, Guoping, et al.
Publicado: (2020)

Genetic modifiers regulating DNA replication and double strand break repair are associated with differences in mammary tumors in mouse models of Li-Fraumeni Syndrome
por: Majhi, Prabin Dhangada, et al.
Publicado: (2021)

Opportunities for Ferroptosis in Cancer Therapy
por: Fujihara, Kenji M., et al.
Publicado: (2021)

Restoring p53 in cancer: the promises and the challenges
por: Lozano, Guillermina
Publicado: (2019)

Cancer-associated fibroblasts: challenges and opportunities
por: Tavana, Hossein, et al.
Publicado: (2023)

Translation Control by p53
por: Kasteri, Justina, et al.
Publicado: (2018)

Targeting mutant p53 for cancer therapy
por: Oren, Moshe, et al.
Publicado: (2016)

A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic opportunity
por: Ory, Benjamin, et al.
Publicado: (2011)

The many faces of p53: something for everyone
por: Levine, Arnold J
Publicado: (2019)

Conservation Genetics of the Cheetah: Lessons Learned and New Opportunities
por: O’Brien, Stephen J, et al.
Publicado: (2017)

Gain-of-function mutant p53: history and speculation
por: Bargonetti, Jill, et al.
Publicado: (2019)

Mutant p53: it’s not all one and the same
por: Kennedy, Margaret C., et al.
Publicado: (2022)

Cuproptosis: p53-regulated metabolic cell death?
por: Xiong, Chen, et al.
Publicado: (2023)

Cholesterol esterification and p53-mediated tumor suppression
por: Li, Youjun, et al.
Publicado: (2023)

Dairy cows – an opportunity in the research field of non-genetic inheritance?
por: Engmann, Olivia
Publicado: (2018)

p53 and Ca(2+) signaling from the endoplasmic reticulum: partners in anti-cancer therapies
por: Bittremieux, Mart, et al.
Publicado: (2015)

Host-directed therapy, an untapped opportunity for antimalarial intervention
por: Wei, Ling, et al.
Publicado: (2021)

Genetically modified T cells in cancer therapy: opportunities and challenges
por: Sharpe, Michaela, et al.
Publicado: (2015)

Taking up the reins of power: metabolic functions of p53
por: Humpton, Timothy, et al.
Publicado: (2019)

Milk disrupts p53 and DNMT1, the guardians of the genome: implications for acne vulgaris and prostate cancer
por: Melnik, Bodo C.
Publicado: (2017)

Knockout and transgenic mice of Trp53: what have we learned about p53 in breast cancer?
por: Blackburn, Anneke C, et al.
Publicado: (2002)

Targeting ACE2 for COVID-19 Therapy: Opportunities and Challenges
por: Jia, Hongpeng, et al.
Publicado: (2021)

The role of p53 in reproduction, an unexpected function for a tumor suppressor
por: Hu, Wenwei, et al.
Publicado: (2019)

Context is everything: extrinsic signalling and gain-of-function p53 mutants
por: Amelio, Ivano, et al.
Publicado: (2020)

Cross-talk between Myc and p53 in B-cell lymphomas
por: Yu, Li, et al.
Publicado: (2019)

p53 Signaling in Cancers
por: Issaeva, Natalia
Publicado: (2019)

Cancer Cachexia and Dysregulated Phosphate Metabolism: Insights from Mutant p53 and Mutant Klotho Mouse Models
por: Brown, Ronald B.
Publicado: (2022)

Using Genetic Testing at Cancer Diagnosis for Breast Cancer Control
por: Sun, Li, et al.
Publicado: (2022)

Past evolutionary tradeoffs represent opportunities for crop genetic improvement and increased human lifespan
por: Denison, R Ford
Publicado: (2011)

Gene editing therapy ready for cardiovascular diseases: opportunities, challenges, and perspectives
por: Zhou, Jun, et al.
Publicado: (2021)

p53 and FBXW7: Sometimes Two Guardians Are Worse than One
por: Galindo-Moreno, María, et al.
Publicado: (2020)

Mutant p53—a potential player in shaping the tumor–stroma crosstalk
por: Stein, Yan, et al.
Publicado: (2019)

Global progress against cancer—challenges and opportunities
por: Biemar, Frédéric, et al.
Publicado: (2013)

Tackling Thyroid Cancer in Europe—The Challenges and Opportunities
por: Horgan, Denis, et al.
Publicado: (2022)

Progress in targeted therapy for breast cancer
por: Ju, Jie, et al.
Publicado: (2018)

Monitoring vascular normalization: new opportunities for mitochondrial inhibitors in breast cancer
por: Mouron, Silvana, et al.
Publicado: (2021)

Behavioural and social science research opportunities
por: Carrasco, Maria A, et al.
Publicado: (2021)

Metformin and breast cancer: an opportunity for pharmacogenetics
por: Cuyàs, Elisabet, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qclfm8o6vpme7a7d3iot7q5qr3